含的药物:扩大抗病毒疗法的视野
Hamza Tachallait1, Leticia Christina Pires Goncalves2, Rachid Benhida3
1Chemical & Biochemical Sciences Green-Process Engineering (CBS) Mohammed VI Polytechnic University, Lot 660, Hay Moulay Rachid, 43150, Benguerir, Morocco.
European journal of medicinal chemistry
|October 21, 2025
概括
含的药物对于抗病毒疗法至关重要,为药物设计和有效性提供独特的特性. 本综述详细介绍了它们的结构,作用和针对病毒威胁的应用.
科学领域:
- 药用化学 医学化学
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
背景情况:
- 含的化合物对于开发抗病毒药物至关重要.
- 它们独特的化学特性使得它们在药物设计和分子相互作用中发挥了多种作用.
- 这些药物是对抗病毒感染的关键.
研究的目的:
- 提供含的抗病毒药物的全面审查.
- 探索它们的结构多样性,作用机制和治疗用途.
- 突出基抗病毒药物的扩大潜力.
主要方法:
- 将含的抗病毒药物分为三个主要类别:循环核酸相似物,非循环核酸酸盐和含非核酸的药物.
- 讨论代表性药物,包括雷梅西维尔,特诺福维尔,奇多福维尔和佛斯卡内特.
- 探索前药物策略,以克服药物动力学挑战.
主要成果:
- 原子增强了药物的稳定性,生物可用性和特异性.
- 代表性药物表现出针对病毒复制的多种机制.
- 亲药物策略可以提高这些抗病毒药物的输送和有效性.
结论:
- 基于的抗病毒药物代表着一个重要的和不断增长的治疗类别.
- 这些药物对于应对当前和新出现的病毒威胁至关重要.
- 对含化合物的进一步研究有望为未来的抗病毒药物开发提供希望.
相关概念视频
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
202
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
202
Subviral Agents
512
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
512
Phosphoinositides and PIPs
10.1K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Pharmacokinetics: Drug–Drug Interactions
349
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
349
Principles of Drug Action
8.1K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
8.1K


